after a baseline period to ensure that asthma control was stable subjects entered the treatment period , during which they inhaled sodium cromoglycate 20 mg four times daily or matching placebo four times daily for 16 weeks each , in random order .
C0004096
asthma
C0012694
sodium cromoglycate